Is Kenvue (KVUE) overvalued or fairly valued?

MarketChacha shows Kenvue's valuation in context — a forward P/E of about 15.5, a price-to-book of about 3.5 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of Kenvue (KVUE)?

Kenvue last traded at $19.18 (+0.9% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Kenvue

KVUE · NYSE · Consumer Staples · United States

$19.18+0.9%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 5:40 PM

Snapshot

TickerKVUE

ExchangeNYSE

SectorConsumer Staples

IndustryHousehold & Personal Products

CountryUnited States

Employees21,780

HeadquartersSummit, United States

Market cap$36.8B

P/B3.5

Volume3.93M

Websitewww.kenvue.com

Filings tracked0

About Kenvue

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Profile as reported by Yahoo Finance.

Who owns it

Insiders0.1%
Institutions95.0%
Public & other4.9%

1,390 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.7.57%
FMR, LLC7.04%
Vanguard Capital Management LLC6.48%
State Street Corporation6.23%
Vanguard Portfolio Management LLC4.82%
Pentwater Capital Management Lp2.71%
Geode Capital Management, LLC2.67%
Massachusetts Financial Services Co.2.59%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $3.9B · EPS 0.30

Est. earnings growth +8.1%

Next fiscal year

Rev $16.0B · EPS 1.24

Est. earnings growth +4.7%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$14.0252-wk range$22.87

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about KVUE

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.